VIR — VIR BIOTECHNOLOGY INC

Ownership history in Persistent Asset Partners Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Persistent Asset Partners Ltd reported a position in VIR BIOTECHNOLOGY INC (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.21% (2024 Q4)
Avg. % of fund
0.19%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 63,550 +39,481 +164.0% 0.17% $383K $6.03
2024 Q4 INITIATED 24,069 — — 0.21% $250K $7.34
% of Fund (quarterly)    VIR price (monthly, adj. close)

Other funds also holding VIR

As of 2025 Q4 — sorted by position size

ARCH Venture Management, LLC 3Y 7Y 11.95% GSK plc 6.45% GordonMD Global Investments LP 4.02% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 0.79% Sio Capital Management, LLC 3Y 7Y 0.45% Tejara Capital Ltd 3Y 0.33% Eagle Health Investments LP 3Y 0.32% ORBIMED ADVISORS LLC 3Y 7Y 0.29% Ikarian Capital, LLC 3Y 0.27% Clarius Group, LLC 3Y 7Y 0.21%
← Back to Persistent Asset Partners Ltd Holdings